| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PD 153035 | CTRPv2 | pan-cancer | AAC | -0.057 | 0.2 |
| mRNA | salermide | CTRPv2 | pan-cancer | AAC | -0.062 | 0.2 |
| mRNA | Erlotinib | FIMM | pan-cancer | AAC | 0.25 | 0.2 |
| mRNA | triptolide | CTRPv2 | pan-cancer | AAC | 0.048 | 0.2 |
| mRNA | BRD-K49290616 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.2 |
| mRNA | Axitinib | FIMM | pan-cancer | AAC | 0.23 | 0.2 |
| mRNA | TGX221 | CTRPv2 | pan-cancer | AAC | -0.049 | 0.2 |
| mRNA | NSC 74859 | CTRPv2 | pan-cancer | AAC | -0.051 | 0.2 |
| mRNA | VER-155008 | CTRPv2 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | 0.043 | 0.2 |